A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Different patients have different biomarkers, if doctors know about the
biomarkers of patients; they may be able to prescribe a regimen that is better suited to the
patient's specific needs. This is a pilot study. Here, we used whole exon sequencing and
Integrated genomic network analysis to identify the biomarker or gene. We aimed to learn if
the drug chosen based on biomarkers can help to control metastatic gastrointestinal cancer
who had failed from all standard and available regimens.